Skip to content

A Study to Evaluate the Product Performance of a Low Add MultiFocal Soft Contact Lens

A Study to Evaluate the Product Performance of a Low Add MultiFocal Soft Contact Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01539694
Enrollment
126
Registered
2012-02-27
Start date
2012-01-31
Completion date
2012-03-31
Last updated
2020-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Brief summary

The objective of this study is to evaluate the product performance of an investigational multifocal low add soft contact lens.

Interventions

DEVICELD118033 contact lens

Multifocal contact lens worn on a daily wear basis for 1 week

DEVICEPureVision multifocal contact lens

PureVision multifocal contact lens worn on a daily wear basis for 1 week.

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SCREENING
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have physiologically normal anterior segments. * Be adapted wearers of soft contact lenses and wear a lens in each eye. * Be presbyopic and require near add correction in each eye. * Have no active ocular disease or allergic conjunctivitis. * Must not be using any topical ocular medications.

Exclusion criteria

* Any Grade 2 or greater finding during the slit lamp examination. * Any scar or neovascularization within the central 4mm of the cornea. * Any Present finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear. * Allergic to any component in the study products. * Any systemic disease affecting ocular health. * Using any systemic or topical medications that will affect ocular physiology or lens performance. * An active ocular disease, any corneal infiltrative response or are using any ocular medications.

Design outcomes

Primary

MeasureTime frameDescription
Visual AcuityAt 1 week follow upVisual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).

Secondary

MeasureTime frameDescription
Symptoms/ComplaintsAt 1 week follow upSymptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.

Countries

United States

Participant flow

Recruitment details

A total of 126 participants (252 eyes) were enrolled. One-half of the participants were randomized to receive the investigational contact lens during the first crossover period, and the other half were randomized to receive the PureVision contact lens during the first crossover period. The participants crossed over to the other group at 1 week.

Participants by arm

ArmCount
Overall
All participants/eyes received both treatment groups.
124
Total124

Baseline characteristics

CharacteristicOverall
Age, Continuous47.0 years
STANDARD_DEVIATION 4.7
Sex: Female, Male
Female
93 Participants
Sex: Female, Male
Male
31 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1260 / 126
serious
Total, serious adverse events
0 / 1260 / 126

Outcome results

Primary

Visual Acuity

Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).

Time frame: At 1 week follow up

Population: There were 124 eligible, dispensed participants (248 eyes). Participants/eyes received both treatment groups.

ArmMeasureValue (MEAN)Dispersion
LD118033 Contact LensVisual Acuity0.023 logMARStandard Deviation 0.078
PureVision Multifocal Contact LensVisual Acuity0.005 logMARStandard Deviation 0.069
Secondary

Symptoms/Complaints

Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints.

Time frame: At 1 week follow up

Population: There were 124 eligible, dispensed participants (248 eyes). Participants/eyes received both treatment groups.

ArmMeasureGroupValue (MEAN)Dispersion
LD118033 Contact LensSymptoms/ComplaintsBurning/stinging upon insertion91.3 score on a scaleStandard Deviation 12.6
LD118033 Contact LensSymptoms/ComplaintsComfort upon insertion87.0 score on a scaleStandard Deviation 16.6
LD118033 Contact LensSymptoms/ComplaintsComfort at end of day72.5 score on a scaleStandard Deviation 24.4
LD118033 Contact LensSymptoms/ComplaintsOverall comfort79.2 score on a scaleStandard Deviation 21.2
LD118033 Contact LensSymptoms/ComplaintsDryness78.7 score on a scaleStandard Deviation 22.4
LD118033 Contact LensSymptoms/ComplaintsItchiness89.1 score on a scaleStandard Deviation 17
LD118033 Contact LensSymptoms/ComplaintsRedness91.9 score on a scaleStandard Deviation 12.3
LD118033 Contact LensSymptoms/ComplaintsDistance Vision69.3 score on a scaleStandard Deviation 30.4
LD118033 Contact LensSymptoms/ComplaintsVision at intermediate distance81.2 score on a scaleStandard Deviation 20.3
LD118033 Contact LensSymptoms/ComplaintsVision at near distance76.3 score on a scaleStandard Deviation 25.7
LD118033 Contact LensSymptoms/ComplaintsOverall vision72.9 score on a scaleStandard Deviation 25.8
LD118033 Contact LensSymptoms/ComplaintsEase of handling/insertion85.7 score on a scaleStandard Deviation 18.8
LD118033 Contact LensSymptoms/ComplaintsEase of handling/removal88.5 score on a scaleStandard Deviation 17.2
LD118033 Contact LensSymptoms/ComplaintsOverall impression24.7 score on a scaleStandard Deviation 24
PureVision Multifocal Contact LensSymptoms/ComplaintsOverall vision73.7 score on a scaleStandard Deviation 22.7
PureVision Multifocal Contact LensSymptoms/ComplaintsBurning/stinging upon insertion89.2 score on a scaleStandard Deviation 16.9
PureVision Multifocal Contact LensSymptoms/ComplaintsDistance Vision76.5 score on a scaleStandard Deviation 23.3
PureVision Multifocal Contact LensSymptoms/ComplaintsComfort upon insertion83.9 score on a scaleStandard Deviation 18
PureVision Multifocal Contact LensSymptoms/ComplaintsEase of handling/removal87.5 score on a scaleStandard Deviation 17.5
PureVision Multifocal Contact LensSymptoms/ComplaintsComfort at end of day68.1 score on a scaleStandard Deviation 25
PureVision Multifocal Contact LensSymptoms/ComplaintsVision at intermediate distance80.7 score on a scaleStandard Deviation 18.3
PureVision Multifocal Contact LensSymptoms/ComplaintsOverall comfort74.6 score on a scaleStandard Deviation 22.9
PureVision Multifocal Contact LensSymptoms/ComplaintsEase of handling/insertion85.4 score on a scaleStandard Deviation 19.7
PureVision Multifocal Contact LensSymptoms/ComplaintsDryness75.2 score on a scaleStandard Deviation 23.7
PureVision Multifocal Contact LensSymptoms/ComplaintsVision at near distance72.2 score on a scaleStandard Deviation 26.2
PureVision Multifocal Contact LensSymptoms/ComplaintsItchiness84.5 score on a scaleStandard Deviation 21.1
PureVision Multifocal Contact LensSymptoms/ComplaintsOverall impression74.6 score on a scaleStandard Deviation 22.7
PureVision Multifocal Contact LensSymptoms/ComplaintsRedness87.0 score on a scaleStandard Deviation 18

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026